🇺🇸 FDA
Patent

US 10179919

Multigenome retroviral vector preparations and methods and systems for producing and using same

granted A61KA61K2039/5256A61K2039/70

Quick answer

US patent 10179919 (Multigenome retroviral vector preparations and methods and systems for producing and using same) held by IMMUNE DESIGN CORP. expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
IMMUNE DESIGN CORP.
Grant date
Tue Jan 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K2039/5256, A61K2039/70, A61K39/0011, A61K39/001102